Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAligos Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Aligos Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jun 25, 2026Hirth PeterDirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Jun 25, 2026Nuechterlein CaroleDirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Jun 25, 2026Scopa James PaulDirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Jun 25, 2026Martell Bridget ADirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Jun 25, 2026Chavez MargaritaDirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Jun 25, 2026Preston HeatherDirector5,860Stock Option (Right to Buy)$30.9KGrant / award
Mar 9, 2026BLATT LAWRENCEPresident and CEO105,840Stock Option (Right to Buy)$738.8KGrant / award
Mar 9, 2026Calhoun Lesley AnnSee Remarks37,485Stock Option (Right to Buy)$261.6KGrant / award
Mar 9, 2026Aneja NikhilPrincipal Accounting Officer9,450Stock Option (Right to Buy)$66KGrant / award
Mar 9, 2026Symons Julian A.See Remarks23,310Stock Option (Right to Buy)$162.7KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$5.68Close · Sep 22, 2026